IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 14 | -98.7% | 0.00% | -100.0% |
| Q1 2022 | $18,000 | -95.9% | 1,077 | -92.2% | 0.00% | -95.5% |
| Q1 2021 | $439,000 | +112.1% | 13,881 | +120.8% | 0.02% | +69.2% |
| Q3 2020 | $207,000 | -5.9% | 6,288 | -21.7% | 0.01% | -7.1% |
| Q2 2020 | $220,000 | +18.9% | 8,029 | +30.6% | 0.01% | 0.0% |
| Q1 2020 | $185,000 | -17.0% | 6,149 | -23.5% | 0.01% | 0.0% |
| Q4 2019 | $223,000 | +92.2% | 8,034 | +26.4% | 0.01% | +75.0% |
| Q3 2019 | $116,000 | +300.0% | 6,356 | +453.2% | 0.01% | +300.0% |
| Q2 2019 | $29,000 | +222.2% | 1,149 | +20.8% | 0.00% | +100.0% |
| Q1 2019 | $9,000 | 0.0% | 951 | -9.4% | 0.00% | 0.0% |
| Q4 2018 | $9,000 | +200.0% | 1,050 | +205.2% | 0.00% | – |
| Q3 2018 | $3,000 | -100.0% | 344 | -75.6% | 0.00% | -100.0% |
| Q2 2018 | $18,073,000 | +64446.4% | 1,412 | -12.8% | 0.00% | -33.3% |
| Q1 2018 | $28,000 | +211.1% | 1,620 | +46.3% | 0.00% | +200.0% |
| Q4 2017 | $9,000 | +350.0% | 1,107 | +369.1% | 0.00% | – |
| Q3 2017 | $2,000 | -84.6% | 236 | -86.3% | 0.00% | -100.0% |
| Q2 2017 | $13,000 | – | 1,725 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |